Chi Sheng Pharma & Biotech Co., Ltd. (4111) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Chi Sheng Pharma & Biotech Co., Ltd. (4111:TWSE), powered by AI.

Current Price
$29.95
Sector
Healthcare
What is the Chi Sheng Pharma & Biotech Co., Ltd. stock price forecast?

Chi Sheng Pharma & Biotech Co., Ltd. is currently trading at $29.95. View real-time AI analysis on Alpha Lenz.

What is Chi Sheng Pharma & Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Chi Sheng Pharma & Biotech Co., Ltd. on Alpha Lenz.

What is Chi Sheng Pharma & Biotech Co., Ltd.'s P/E ratio?

View Chi Sheng Pharma & Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

Chi Sheng Pharma & Biotech Co., Ltd.

TWSE · 4111
NT$29.95+0.00(+0.00%)
Ask about Chi Sheng Pharma & Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Chi Sheng Pharma & Biotech Co., Ltd.'s ROE is 12.4%. Explore profitability and growth together.

Ask for details

Company Overview

Chi Sheng Pharma & Biotech Co., Ltd. is a leading pharmaceutical and biotechnology company focused on the manufacturing and distribution of medical medicines, equipment, and consumable healthcare products. Established in 1962 and headquartered in Hsinchu, Taiwan, the company has a diversified portfolio that includes injectable treatments—such as hemodialysis solutions, amino acid and vitamin injections—as well as oral medicines such as antibiotics, cough syrups, and gastrointestinal treatments. In addition to internally and externally applied pharmaceuticals, it offers products like contact lens solutions, saline, and iodine, along with healthcare foods and select medical devices. Chi Sheng Pharma & Biotech Co., Ltd. serves both the domestic Taiwanese market and exports to China and Southeast Asia. Operating within the major pharmaceuticals segment of the health technology sector, the company plays a vital role in supporting clinical care and public health infrastructure through its comprehensive product offerings and long-standing presence in the market.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.38BRevenue
0.00Shares Out
0Employees

Margins

39.50%Gross
20.46%EBITDA
14.48%Operating
15.02%Pre-Tax
11.93%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.39%Rev 3Yr
7.04%Rev 5Yr
9.02%Op Inc 3Yr
21.41%Op Inc 5Yr
2.18%Net Inc 3Yr
22.67%Net Inc 5Yr

Returns

8.91%ROA
12.37%ROE
11.24%ROIC

Financial Health

NT$443.91MCash & Cash Equivalents
NT$113.14MNet Debt
40.34%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Chi Sheng Pharma & Biotech Co., Ltd. (ticker: 4111) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 29.95 with a P/E ratio of -x and P/B of -x.

ROE is 12.37% and operating margin is 14.48%. Annual revenue is $1.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Chi Sheng Pharma & Biotech Co., Ltd. (4111) Stock Forecast 2026 $29.95 — Price, Financials & Analyst Targets | Alpha Lenz